Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies

Meeting Date: 
Wednesday, August 20, 2025

Time:
12:00-1:00 PM ET

Location:
Indiana University Health Bloomington Hospital
Bloomington, IN

Faculty Speaker:
Nick McAndrew MD, MSCE

Pin It on Pinterest

Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers